Abexxa Biologics, Inc. Email Format
Pharmaceutical ManufacturingTexas, United States2-10 Employees
Abexxa Biologics, Inc. is a biopharmaceutical company focused on immuno-oncology and oncology, pursuing a precision medicine approach by targeting intracellular atypical HLA-peptide complexes on cancer cells. Its work centers on discovering and validating targets and generating highly specific human antibodies for various therapeutic formats, including direct tumor killing and immune-modulated tumor death. The company aims to address cancer treatment challenges by accessing targets previously considered undruggable and by modulating innate and adaptive immune responses. Based in Arlington, Texas, Abexxa operates in the pharmaceutical manufacturing industry as a small organization developing novel therapeutic candidates for cancer therapy. A notable development in its history is the acquisition by Boehringer Ingelheim in 2021, reflecting its prior recognition within academic and industry collaborations.